"Zadbamy o Twoje zdrowie, gdy wyjeżdżasz za granicę, szukasz specjalisty czy chcesz się zaszczepić. Specjalizujemy się w: medycynie podróży, chorobach tropikalnych, pediatrii, medycynie estetycznej, psychiatrii, immunologii oraz reumatologii."

During the past decade, Provita Profamilia conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Provita Profamilia" #1 sponsor was "Pfizer" with 3 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "BioNTech SE" with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Incyte Biosciences International Sàrl" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Provita Profamilia" #1 collaborator was "Duke Clinical Research Institute" with 1 trials as a collaborator, "Memorial Sloan Kettering Cancer Center" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Provita Profamilia" are "Prostate Cancer" (2 trials), "Abiraterone Acetate" (1 trials), "Androgens" (1 trials), "Antineoplastic Agents" (1 trials) and "Antineoplastic Agents, Hormonal" (1 trials). Many other conditions were trialed in "Provita Profamilia" in a lesser frequency.

Most popular intervention types in "Provita Profamilia" are "Drug" (8 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials), "Abemaciclib" (1 trials) and "Abiraterone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Provita Profamilia" are 7 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Provita Profamilia". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Provita Profamilia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Provita Profamilia, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".